Charles A. Baker, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 5,000 shares at $550.00 ($2.8M) on 2015-09-17, disclosed to the SEC on 2015-09-18.
Scheduled sale ($2.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2015-03-26 | $2.3M | — | Filing → |
| REGN | SELL | 2014-03-25 | $4.5M | — | Filing → |
| REGN | SELL | 2013-10-02 | $4.7M | — | Filing → |